Atricure Inc. buy JPMorgan Chase & Co.
Start price
27.03.25
/
50%
€29.29
Target price
27.03.26
€42.73
Performance (%)
-16.01%
End price
28.03.26
€24.60
Summary
This prediction ended on 28.03.26 with a price of €24.60. The price of Atricure Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.01%. JPMorgan_Chase___Co_ has a follow-up prediction for Atricure Inc. where he still thinks Atricure Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | -4.032% | -4.032% | -61.613% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target lowered by analysts at JPMorgan Chase & Co. from $51.00 to $46.00. They now have an "overweight" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten